All you need to know in one place
Secure your 503B supply with SCA Pharma and Medigi Supply chain disruptions keep pharmacy leaders awake at night. When unexpected market shifts threaten your access to essential medications, patient safety hangs in the balance. You need a reliable 503B outsourcing partner to step in and fill those crucial inventory gaps immediately. SCA Pharma offers healthcare…
As part of our ongoing commitment to reliability, accessibility, and quality in the healthcare supply chain, SCA Pharma is pleased to announce an expanded distribution approach for our core pharmaceutical products. Healthcare professionals can now access SCA Pharma’s trusted offerings through a broader network of purchasing platforms, including Medigi as an alternate location. This important…
Windsor, CT, November 1, 2022– SCA Pharma, a nationally recognized leader in the 503B compounded pharmaceuticals outsourcing industry, providing quality, service, and value to hospitals nationwide, has announced today that Vizient has awarded a multi-year agreement to the company for its full range of 503B ready-to-use products. Vizient is one of the nation’s leading health…
On January 27, 2022, the FDA announced its decision to not include Glycopyrrolate on the 503B bulks list. Following this announcement, outsourcing facilities will not be permitted to compound the drug-using bulk API, unless the product appears in the future on the FDA’s drug shortage list. Glycopyrrolate is not currently on the drug shortage list.…
SCA Pharma, which provides high-quality sterile admixture services to hospitals and health-care facilities nationwide, has named Scott Luce as Chief Executive Officer.
SCA Pharma is proud to honor these essential front-line providers during National Nurses Month.
Reflecting its unequivocal commitment to leading the 503B compounded pharmaceuticals outsourcing industry in excellence, SCA Pharmaceuticals has named Abby Kaplan as General Counsel and Chief Compliance Officer.
In our ongoing effort to enhance our customers’ experience, SCA Pharma has responded to feedback and made several changes to the customer portal. Here are recent updates: Watch for a “chat” feature coming soon. To see these recent changes, log in to the customer portal here or contact a salesperson for help placing an order…
SCA Pharmaceuticals continues its aggressive expansion and implementation of growth strategies, and in doing so, has appointed Joe Akers as Chief Operating Officer.
WINDSOR, CONN. (Jan. 28, 2021)– SCA Pharmaceuticals, LLC, announced details last week of their acquisition by The Vistria Group and Excellere. Continuing their strategic growth initiatives, SCA Pharma is announcing the appointment of Mr. Scott Luce as Chief Commercial Officer. Mr. Luce will provide leadership and oversight of commercial operations as SCA Pharma continues to…